These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 22265123)

  • 1. Meningococcal vaccine: a position statement of the society for adolescent health and medicine.
    Ipp LS; Breuner CC; Middleman AB;
    J Adolesc Health; 2012 Feb; 50(2):211-2. PubMed ID: 22265123
    [No Abstract]   [Full Text] [Related]  

  • 2. Statement on meningococcal vaccination for travellers. An Advisory Committee Statement (ACS).
    Committee to Advise on Tropical Medicine (CATMAT)
    Can Commun Dis Rep; 2009 Jun; 35(ACS-4):1-22. PubMed ID: 19526652
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical practice. Prevention of meningococcal disease.
    Gardner P
    N Engl J Med; 2006 Oct; 355(14):1466-73. PubMed ID: 17021322
    [No Abstract]   [Full Text] [Related]  

  • 4. Epidemiology and meningococcal serogroup distribution in the United States.
    Hershey JH; Hitchcock W
    Clin Pediatr (Phila); 2010 Jun; 49(6):519-24. PubMed ID: 20507868
    [No Abstract]   [Full Text] [Related]  

  • 5. Neisseria vaccines 2007 - international workshop.
    Martin D
    IDrugs; 2007 Jul; 10(7):450-2. PubMed ID: 17642012
    [No Abstract]   [Full Text] [Related]  

  • 6. An update on the invasive meningococcal disease and meningococcal vaccine conjugate recommendations. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2009 Apr; 35(ACS-3):1-40. PubMed ID: 19400026
    [No Abstract]   [Full Text] [Related]  

  • 7. The risk of meningococcal disease in travelers and current recommendations for prevention.
    Steffen R
    J Travel Med; 2010; 17 Suppl():9-17. PubMed ID: 20849428
    [No Abstract]   [Full Text] [Related]  

  • 8. Vaccine research: new vaccines and evidence of vaccine safety.
    Commun Dis Rep CDR Wkly; 1999 May; 9(19):167, 170. PubMed ID: 10334064
    [No Abstract]   [Full Text] [Related]  

  • 9. Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines.
    Trotter CL; Ramsay ME
    FEMS Microbiol Rev; 2007 Jan; 31(1):101-7. PubMed ID: 17168998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent trends in meningococcal epidemiology and current vaccine recommendations.
    Baltimore RS
    Curr Opin Pediatr; 2006 Feb; 18(1):58-63. PubMed ID: 16470164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Licensure of a meningococcal conjugate vaccine (Menveo) and guidance for use - Advisory Committee on Immunization Practices (ACIP), 2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Mar; 59(9):273. PubMed ID: 20224545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Advisory Committee Statement (ACS). Statement on recommended use of meningococcal vaccines.
    National Advisory Committee on Immunisation (NACI)
    Can Commun Dis Rep; 2001 Oct; 27():2-36. PubMed ID: 11706686
    [No Abstract]   [Full Text] [Related]  

  • 13. Meningococcal disease: a review on available vaccines and vaccines in development.
    Bröker M; Fantoni S
    Minerva Med; 2007 Oct; 98(5):575-89. PubMed ID: 18043565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges for development of meningococcal vaccines in infants and children.
    Deasy A; Read RC
    Expert Rev Vaccines; 2011 Mar; 10(3):335-43. PubMed ID: 21434801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Meningococcal vaccine. Editorial].
    Gendrel D; Cohen R
    Arch Pediatr; 2012 Sep; 19 Suppl 2():S47-8. PubMed ID: 22883365
    [No Abstract]   [Full Text] [Related]  

  • 16. Early estimate of the effectiveness of quadrivalent meningococcal conjugate vaccine.
    Macneil JR; Cohn AC; Zell ER; Schmink S; Miller E; Clark T; Messonnier NE;
    Pediatr Infect Dis J; 2011 Jun; 30(6):451-5. PubMed ID: 21206392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timing of adolescent meningococcal conjugate vaccination attitudes and practices of pediatricians and family medicine physicians.
    Allison MA; Cohn AC; Stokley S; Crane LA; O'Leary ST; Hurley LP; Babbel CI; Dong F; Gahm C; Temte JL; Kempe A
    Am J Prev Med; 2011 Dec; 41(6):581-7. PubMed ID: 22099234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccines for the poor: meningococcal A conjugate vaccine in Africa.
    Isaacs D
    J Paediatr Child Health; 2011 Jan; 47(1-2):66. PubMed ID: 21255149
    [No Abstract]   [Full Text] [Related]  

  • 19. [Advances in vaccines and invasive disease in children].
    Moraga Llop FA
    Rev Esp Quimioter; 2001 Dec; 14(4):319-30. PubMed ID: 11856977
    [No Abstract]   [Full Text] [Related]  

  • 20. Optimizing protection against meningococcal disease.
    Reisinger KS; Black S; Stoddard JJ
    Clin Pediatr (Phila); 2010 Jun; 49(6):586-97. PubMed ID: 20089551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.